Liza Laws

Donanemab marks a significant advancement in Alzheimer’s treatment, but NHS patients face a setback with NICE's rejection of its cost-effectiveness.

In an exclusive interview, Vicky shares insights on her career, the challenges she faced, and her passion for inspiring the next generation of women in science.

Janssen-Cilag International NV's European Commission (EC) approval extends the Darzalex (daratumumab) subcutaneous (SC) formulation for use in combination with bortezomib, lenalidomide, and dexamethasone.

Anu Codaty, VP of global marketing and strategy at Aldevron, is blazing trails in biotech, inspired by a family legacy in medicine and driven to create life-changing therapies.

This alliance marks a shift in biopharma R&D, with the launch of the Biophysics Institute for Biomedical Research (IBRB), offering top-tier scientific instrumentation and collaborative research support.

Riccardo Butta, a leader at Stevanato Group, delves into how cutting-edge digital twin technology, advanced data management, and AI-driven systems are transforming manufacturing efficiency and quality in the pharmaceutical sector.

Anu Codaty, VP of global marketing and strategy at Aldevron, is blazing trails in biotech, inspired by a family legacy in medicine and driven to create life-changing therapies.

At CPHI Milan 2024, Abzena showcased its latest innovations in cell line development and ADC manufacturing, featuring the advanced AbZelectPRO platform and ThioBridge linker technology.

A new case study from AllazoHealth demonstrates that a top 10 rare disease pharmaceutical company experienced a 10.4% increase in therapy initiation through AI-driven patient outreach and tailored, multi-channel communications.

Thermo Fisher Scientific has joined forces with Labguru to integrate Labguru’s Electronic Lab Notebook (ELN) into Thermo Fisher’s Laboratory Information Management System (LIMS) and lab operations software.